Edgewise Therapeutics Inc Cash Flow Quality Index

Latest as of December 2025: -0.33x

Edgewise Therapeutics Inc cash flow quality index. Edgewise Therapeutics Inc (EWTX) has a Cash Flow Quality Index of -0.33x as of December 2025. Operating cash flow of $-38.59 Million is below net income of $117.58 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Edgewise Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.33x
Operating CF / Net Income

Operating Cash Flow

$-38.59 Million
USD

Net Income

$117.58 Million
USD

Data as of

Dec 2025
Most recent filing

Edgewise Therapeutics Inc Cash Flow Quality Index by Year (None–None)

Edgewise Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Edgewise Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Edgewise Therapeutics Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.